Summary

Dengue Testing Market ? Scope of Report

TMR’s report on the global Dengue Testing Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Dengue Testing Market for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Dengue Testing Market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Global Dengue Testing Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the Global Dengue Testing Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the Global Dengue Testing Market. These serve as valuable tools for existing Market players as well as for entities interested in participating in the Global Dengue Testing Market .

The report delves into the competitive landscape of the Global Dengue Testing Market. Key players operating in the global Dengue Testing Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Dengue Testing Market profiled in this report.

Key Questions Answered in Global Dengue Testing Market Report

? What is the sales/revenue generated by Dengue Testing Market across all regions during the forecast period?
? What are the opportunities in the global Dengue Testing Market?
? What are the major drivers, restraints, opportunities, and threats in the Market?
? Which regional Market is set to expand at the fastest CAGR during the forecast period?
? Which segment is expected to generate the highest revenue globally in 2035?
? Which segment is projected to expand at the highest CAGR during the forecast period?
? What are the Market positions of different companies operating in the global Market?

Global Dengue Testing Market ? Research Objectives and Research Approach

The comprehensive report on the global Dengue Testing Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Dengue Testing Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market Share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the Dengue Testing Market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Dengue Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Dengue Testing Market Analysis and Forecast, 2020-2035
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Healthcare Expenditure across Key Countries / Regions
5.2. Recent Advancements in Dengue Testing
5.3. Pricing Analysis of Dengue Testing
5.4. Regulatory Scenario across Key Regions / Countries
5.5. Reimbursement Landscape across Key Regions / Countries
5.6. PORTER’s Five Forces Analysis
5.7. PESTLE Analysis
5.8. Go-to-Market Strategy for New Market Entrants
5.9. Key Purchase Metrics for End-users
5.10. Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)
5.11. Benchmarking of the Products / Services Offered by the Leading Competitors
6. Global Dengue Testing Market Analysis and Forecast, by Product & Service
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product & Service, 2020-2035
6.3.1. Diagnostic Kits
6.3.1.1. Rapid Diagnostic Tests (RDTs)
6.3.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
6.3.1.3. Polymerase Chain Reaction (PCR) Tests
6.3.1.4. Dengue IgG/IgM Detection Kits
6.3.1.5. Lateral Flow Immunoassay
6.3.1.6. Others
6.3.2. Services
6.3.2.1. Laboratory Services
6.3.2.2. Point-of-Care Services
6.4. Market Attractiveness Analysis, by Product & Service
7. Global Dengue Testing Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2020-2035
7.3.1. Molecular Diagnostics
7.3.2. Serological Tests
7.3.3. Antigen Detection Tests
7.4. Market Attractiveness Analysis, by Technology
8. Global Dengue Testing Market Analysis and Forecast, by Sample Type
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Sample Type, 2020-2035
8.3.1. Whole Blood
8.3.2. Serum / Plasma
8.3.3. Saliva
8.3.4. Cerebrospinal Fluid
8.3.5. Others
8.4. Market Attractiveness Analysis, by Sample Type
9. Global Dengue Testing Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2035
9.3.1. Hospitals and Clinics
9.3.2. Diagnostic Laboratories
9.3.3. Home Care Settings
9.3.4. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Dengue Testing Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2035
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Dengue Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product & Service, 2020-2035
11.2.1. Diagnostic Kits
11.2.1.1. Rapid Diagnostic Tests (RDTs)
11.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
11.2.1.3. Polymerase Chain Reaction (PCR) Tests
11.2.1.4. Dengue IgG/IgM Detection Kits
11.2.1.5. Lateral Flow Immunoassay
11.2.1.6. Others
11.2.2. Services
11.2.2.1. Laboratory Services
11.2.2.2. Point-of-Care Services
11.3. Market Value Forecast, by Technology, 2020-2035
11.3.1. Molecular Diagnostics
11.3.2. Serological Tests
11.3.3. Antigen Detection Tests
11.4. Market Value Forecast, by Sample Type, 2020-2035
11.4.1. Whole Blood
11.4.2. Serum / Plasma
11.4.3. Saliva
11.4.4. Cerebrospinal Fluid
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2020-2035
11.5.1. Hospitals and Clinics
11.5.2. Diagnostic Laboratories
11.5.3. Home Care Settings
11.5.4. Others
11.6. Market Value Forecast, by Country, 2020-2035
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product & Service
11.7.2. By Technology
11.7.3. By Sample Type
11.7.4. By End-user
11.7.5. By Country
12. U.S. Dengue Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product & Service, 2020-2035
12.2.1. Diagnostic Kits
12.2.1.1. Rapid Diagnostic Tests (RDTs)
12.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
12.2.1.3. Polymerase Chain Reaction (PCR) Tests
12.2.1.4. Dengue IgG/IgM Detection Kits
12.2.1.5. Lateral Flow Immunoassay
12.2.1.6. Others
12.2.2. Services
12.2.2.1. Laboratory Services
12.2.2.2. Point-of-Care Services
12.3. Market Value Forecast, by Technology, 2020-2035
12.3.1. Molecular Diagnostics
12.3.2. Serological Tests
12.3.3. Antigen Detection Tests
12.4. Market Value Forecast, by Sample Type, 2020-2035
12.4.1. Whole Blood
12.4.2. Serum / Plasma
12.4.3. Saliva
12.4.4. Cerebrospinal Fluid
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2020-2035
12.5.1. Hospitals and Clinics
12.5.2. Diagnostic Laboratories
12.5.3. Home Care Settings
12.5.4. Others
12.6. Market Attractiveness Analysis
12.6.1. By Product & Service
12.6.2. By Technology
12.6.3. By Sample Type
12.6.4. By End-user
13. Canada Dengue Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product & Service, 2020-2035
13.2.1. Diagnostic Kits
13.2.1.1. Rapid Diagnostic Tests (RDTs)
13.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
13.2.1.3. Polymerase Chain Reaction (PCR) Tests
13.2.1.4. Dengue IgG/IgM Detection Kits
13.2.1.5. Lateral Flow Immunoassay
13.2.1.6. Others
13.2.2. Services
13.2.2.1. Laboratory Services
13.2.2.2. Point-of-Care Services
13.3. Market Value Forecast, by Technology, 2020-2035
13.3.1. Molecular Diagnostics
13.3.2. Serological Tests
13.3.3. Antigen Detection Tests
13.4. Market Value Forecast, by Sample Type, 2020-2035
13.4.1. Whole Blood
13.4.2. Serum / Plasma
13.4.3. Saliva
13.4.4. Cerebrospinal Fluid
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2020-2035
13.5.1. Hospitals and Clinics
13.5.2. Diagnostic Laboratories
13.5.3. Home Care Settings
13.5.4. Others
13.6. Market Attractiveness Analysis
13.6.1. By Product & Service
13.6.2. By Technology
13.6.3. By Sample Type
13.6.4. By End-user
14. Europe Dengue Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product & Service, 2020-2035
14.2.1. Diagnostic Kits
14.2.1.1. Rapid Diagnostic Tests (RDTs)
14.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
14.2.1.3. Polymerase Chain Reaction (PCR) Tests
14.2.1.4. Dengue IgG/IgM Detection Kits
14.2.1.5. Lateral Flow Immunoassay
14.2.1.6. Others
14.2.2. Services
14.2.2.1. Laboratory Services
14.2.2.2. Point-of-Care Services
14.3. Market Value Forecast, by Technology, 2020-2035
14.3.1. Molecular Diagnostics
14.3.2. Serological Tests
14.3.3. Antigen Detection Tests
14.4. Market Value Forecast, by Sample Type, 2020-2035
14.4.1. Whole Blood
14.4.2. Serum / Plasma
14.4.3. Saliva
14.4.4. Cerebrospinal Fluid
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2020-2035
14.5.1. Hospitals and Clinics
14.5.2. Diagnostic Laboratories
14.5.3. Home Care Settings
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020-2035
14.6.1. Germany
14.6.2. UK
14.6.3. France
14.6.4. Italy
14.6.5. Spain
14.6.6. The Netherlands
14.6.7. Rest of Europe
14.7. Market Attractiveness Analysis
14.7.1. By Product & Service
14.7.2. By Technology
14.7.3. By Sample Type
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Germany Dengue Testing Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product & Service, 2020-2035
15.2.1. Diagnostic Kits
15.2.1.1. Rapid Diagnostic Tests (RDTs)
15.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
15.2.1.3. Polymerase Chain Reaction (PCR) Tests
15.2.1.4. Dengue IgG/IgM Detection Kits
15.2.1.5. Lateral Flow Immunoassay
15.2.1.6. Others
15.2.2. Services
15.2.2.1. Laboratory Services
15.2.2.2. Point-of-Care Services
15.3. Market Value Forecast, by Technology, 2020-2035
15.3.1. Molecular Diagnostics
15.3.2. Serological Tests
15.3.3. Antigen Detection Tests
15.4. Market Value Forecast, by Sample Type, 2020-2035
15.4.1. Whole Blood
15.4.2. Serum / Plasma
15.4.3. Saliva
15.4.4. Cerebrospinal Fluid
15.4.5. Others
15.5. Market Value Forecast, by End-user, 2020-2035
15.5.1. Hospitals and Clinics
15.5.2. Diagnostic Laboratories
15.5.3. Home Care Settings
15.5.4. Others
15.6. Market Attractiveness Analysis
15.6.1. By Product & Service
15.6.2. By Technology
15.6.3. By Sample Type
15.6.4. By End-user
16. UK Dengue Testing Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Product & Service, 2020-2035
16.2.1. Diagnostic Kits
16.2.1.1. Rapid Diagnostic Tests (RDTs)
16.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
16.2.1.3. Polymerase Chain Reaction (PCR) Tests
16.2.1.4. Dengue IgG/IgM Detection Kits
16.2.1.5. Lateral Flow Immunoassay
16.2.1.6. Others
16.2.2. Services
16.2.2.1. Laboratory Services
16.2.2.2. Point-of-Care Services
16.3. Market Value Forecast, by Technology, 2020-2035
16.3.1. Molecular Diagnostics
16.3.2. Serological Tests
16.3.3. Antigen Detection Tests
16.4. Market Value Forecast, by Sample Type, 2020-2035
16.4.1. Whole Blood
16.4.2. Serum / Plasma
16.4.3. Saliva
16.4.4. Cerebrospinal Fluid
16.4.5. Others
16.5. Market Value Forecast, by End-user, 2020-2035
16.5.1. Hospitals and Clinics
16.5.2. Diagnostic Laboratories
16.5.3. Home Care Settings
16.5.4. Others
16.6. Market Attractiveness Analysis
16.6.1. By Product & Service
16.6.2. By Technology
16.6.3. By Sample Type
16.6.4. By End-user
17. France Dengue Testing Market Analysis and Forecast
17.1. Introduction
17.1.1. Key Findings
17.2. Market Value Forecast, by Product & Service, 2020-2035
17.2.1. Diagnostic Kits
17.2.1.1. Rapid Diagnostic Tests (RDTs)
17.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
17.2.1.3. Polymerase Chain Reaction (PCR) Tests
17.2.1.4. Dengue IgG/IgM Detection Kits
17.2.1.5. Lateral Flow Immunoassay
17.2.1.6. Others
17.2.2. Services
17.2.2.1. Laboratory Services
17.2.2.2. Point-of-Care Services
17.3. Market Value Forecast, by Technology, 2020-2035
17.3.1. Molecular Diagnostics
17.3.2. Serological Tests
17.3.3. Antigen Detection Tests
17.4. Market Value Forecast, by Sample Type, 2020-2035
17.4.1. Whole Blood
17.4.2. Serum / Plasma
17.4.3. Saliva
17.4.4. Cerebrospinal Fluid
17.4.5. Others
17.5. Market Value Forecast, by End-user, 2020-2035
17.5.1. Hospitals and Clinics
17.5.2. Diagnostic Laboratories
17.5.3. Home Care Settings
17.5.4. Others
17.6. Market Attractiveness Analysis
17.6.1. By Product & Service
17.6.2. By Technology
17.6.3. By Sample Type
17.6.4. By End-user
18. Italy Dengue Testing Market Analysis and Forecast
18.1. Introduction
18.1.1. Key Findings
18.2. Market Value Forecast, by Product & Service, 2020-2035
18.2.1. Diagnostic Kits
18.2.1.1. Rapid Diagnostic Tests (RDTs)
18.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
18.2.1.3. Polymerase Chain Reaction (PCR) Tests
18.2.1.4. Dengue IgG/IgM Detection Kits
18.2.1.5. Lateral Flow Immunoassay
18.2.1.6. Others
18.2.2. Services
18.2.2.1. Laboratory Services
18.2.2.2. Point-of-Care Services
18.3. Market Value Forecast, by Technology, 2020-2035
18.3.1. Molecular Diagnostics
18.3.2. Serological Tests
18.3.3. Antigen Detection Tests
18.4. Market Value Forecast, by Sample Type, 2020-2035
18.4.1. Whole Blood
18.4.2. Serum / Plasma
18.4.3. Saliva
18.4.4. Cerebrospinal Fluid
18.4.5. Others
18.5. Market Value Forecast, by End-user, 2020-2035
18.5.1. Hospitals and Clinics
18.5.2. Diagnostic Laboratories
18.5.3. Home Care Settings
18.5.4. Others
18.6. Market Attractiveness Analysis
18.6.1. By Product & Service
18.6.2. By Technology
18.6.3. By Sample Type
18.6.4. By End-user
19. Spain Dengue Testing Market Analysis and Forecast
19.1. Introduction
19.1.1. Key Findings
19.2. Market Value Forecast, by Product & Service, 2020-2035
19.2.1. Diagnostic Kits
19.2.1.1. Rapid Diagnostic Tests (RDTs)
19.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
19.2.1.3. Polymerase Chain Reaction (PCR) Tests
19.2.1.4. Dengue IgG/IgM Detection Kits
19.2.1.5. Lateral Flow Immunoassay
19.2.1.6. Others
19.2.2. Services
19.2.2.1. Laboratory Services
19.2.2.2. Point-of-Care Services
19.3. Market Value Forecast, by Technology, 2020-2035
19.3.1. Molecular Diagnostics
19.3.2. Serological Tests
19.3.3. Antigen Detection Tests
19.4. Market Value Forecast, by Sample Type, 2020-2035
19.4.1. Whole Blood
19.4.2. Serum / Plasma
19.4.3. Saliva
19.4.4. Cerebrospinal Fluid
19.4.5. Others
19.5. Market Value Forecast, by End-user, 2020-2035
19.5.1. Hospitals and Clinics
19.5.2. Diagnostic Laboratories
19.5.3. Home Care Settings
19.5.4. Others
19.6. Market Attractiveness Analysis
19.6.1. By Product & Service
19.6.2. By Technology
19.6.3. By Sample Type
19.6.4. By End-user
20. The Netherlands Dengue Testing Market Analysis and Forecast
20.1. Introduction
20.1.1. Key Findings
20.2. Market Value Forecast, by Product & Service, 2020-2035
20.2.1. Diagnostic Kits
20.2.1.1. Rapid Diagnostic Tests (RDTs)
20.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
20.2.1.3. Polymerase Chain Reaction (PCR) Tests
20.2.1.4. Dengue IgG/IgM Detection Kits
20.2.1.5. Lateral Flow Immunoassay
20.2.1.6. Others
20.2.2. Services
20.2.2.1. Laboratory Services
20.2.2.2. Point-of-Care Services
20.3. Market Value Forecast, by Technology, 2020-2035
20.3.1. Molecular Diagnostics
20.3.2. Serological Tests
20.3.3. Antigen Detection Tests
20.4. Market Value Forecast, by Sample Type, 2020-2035
20.4.1. Whole Blood
20.4.2. Serum / Plasma
20.4.3. Saliva
20.4.4. Cerebrospinal Fluid
20.4.5. Others
20.5. Market Value Forecast, by End-user, 2020-2035
20.5.1. Hospitals and Clinics
20.5.2. Diagnostic Laboratories
20.5.3. Home Care Settings
20.5.4. Others
20.6. Market Attractiveness Analysis
20.6.1. By Product & Service
20.6.2. By Technology
20.6.3. By Sample Type
20.6.4. By End-user
21. Rest of Europe Dengue Testing Market Analysis and Forecast
21.1. Introduction
21.1.1. Key Findings
21.2. Market Value Forecast, by Product & Service, 2020-2035
21.2.1. Diagnostic Kits
21.2.1.1. Rapid Diagnostic Tests (RDTs)
21.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
21.2.1.3. Polymerase Chain Reaction (PCR) Tests
21.2.1.4. Dengue IgG/IgM Detection Kits
21.2.1.5. Lateral Flow Immunoassay
21.2.1.6. Others
21.2.2. Services
21.2.2.1. Laboratory Services
21.2.2.2. Point-of-Care Services
21.3. Market Value Forecast, by Technology, 2020-2035
21.3.1. Molecular Diagnostics
21.3.2. Serological Tests
21.3.3. Antigen Detection Tests
21.4. Market Value Forecast, by Sample Type, 2020-2035
21.4.1. Whole Blood
21.4.2. Serum / Plasma
21.4.3. Saliva
21.4.4. Cerebrospinal Fluid
21.4.5. Others
21.5. Market Value Forecast, by End-user, 2020-2035
21.5.1. Hospitals and Clinics
21.5.2. Diagnostic Laboratories
21.5.3. Home Care Settings
21.5.4. Others
21.6. Market Attractiveness Analysis
21.6.1. By Product & Service
21.6.2. By Technology
21.6.3. By Sample Type
21.6.4. By End-user
22. Asia Pacific Dengue Testing Market Analysis and Forecast
22.1. Introduction
22.1.1. Key Findings
22.2. Market Value Forecast, by Product & Service, 2020-2035
22.2.1. Diagnostic Kits
22.2.1.1. Rapid Diagnostic Tests (RDTs)
22.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
22.2.1.3. Polymerase Chain Reaction (PCR) Tests
22.2.1.4. Dengue IgG/IgM Detection Kits
22.2.1.5. Lateral Flow Immunoassay
22.2.1.6. Others
22.2.2. Services
22.2.2.1. Laboratory Services
22.2.2.2. Point-of-Care Services
22.3. Market Value Forecast, by Technology, 2020-2035
22.3.1. Molecular Diagnostics
22.3.2. Serological Tests
22.3.3. Antigen Detection Tests
22.4. Market Value Forecast, by Sample Type, 2020-2035
22.4.1. Whole Blood
22.4.2. Serum / Plasma
22.4.3. Saliva
22.4.4. Cerebrospinal Fluid
22.4.5. Others
22.5. Market Value Forecast, by End-user, 2020-2035
22.5.1. Hospitals and Clinics
22.5.2. Diagnostic Laboratories
22.5.3. Home Care Settings
22.5.4. Others
22.6. Market Value Forecast, by Country/Sub-region, 2020-2035
22.6.1. China
22.6.2. India
22.6.3. Japan
22.6.4. South Korea
22.6.5. Australia & New Zealand
22.6.6. ASEAN
22.6.7. Rest of Asia Pacific
22.7. Market Attractiveness Analysis
22.7.1. By Product & Service
22.7.2. By Technology
22.7.3. By Sample Type
22.7.4. By End-user
22.7.5. By Country/Sub-region
23. China Dengue Testing Market Analysis and Forecast
23.1. Introduction
23.1.1. Key Findings
23.2. Market Value Forecast, by Product & Service, 2020-2035
23.2.1. Diagnostic Kits
23.2.1.1. Rapid Diagnostic Tests (RDTs)
23.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
23.2.1.3. Polymerase Chain Reaction (PCR) Tests
23.2.1.4. Dengue IgG/IgM Detection Kits
23.2.1.5. Lateral Flow Immunoassay
23.2.1.6. Others
23.2.2. Services
23.2.2.1. Laboratory Services
23.2.2.2. Point-of-Care Services
23.3. Market Value Forecast, by Technology, 2020-2035
23.3.1. Molecular Diagnostics
23.3.2. Serological Tests
23.3.3. Antigen Detection Tests
23.4. Market Value Forecast, by Sample Type, 2020-2035
23.4.1. Whole Blood
23.4.2. Serum / Plasma
23.4.3. Saliva
23.4.4. Cerebrospinal Fluid
23.4.5. Others
23.5. Market Value Forecast, by End-user, 2020-2035
23.5.1. Hospitals and Clinics
23.5.2. Diagnostic Laboratories
23.5.3. Home Care Settings
23.5.4. Others
23.6. Market Attractiveness Analysis
23.6.1. By Product & Service
23.6.2. By Technology
23.6.3. By Sample Type
23.6.4. By End-user
24. India Dengue Testing Market Analysis and Forecast
24.1. Introduction
24.1.1. Key Findings
24.2. Market Value Forecast, by Product & Service, 2020-2035
24.2.1. Diagnostic Kits
24.2.1.1. Rapid Diagnostic Tests (RDTs)
24.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
24.2.1.3. Polymerase Chain Reaction (PCR) Tests
24.2.1.4. Dengue IgG/IgM Detection Kits
24.2.1.5. Lateral Flow Immunoassay
24.2.1.6. Others
24.2.2. Services
24.2.2.1. Laboratory Services
24.2.2.2. Point-of-Care Services
24.3. Market Value Forecast, by Technology, 2020-2035
24.3.1. Molecular Diagnostics
24.3.2. Serological Tests
24.3.3. Antigen Detection Tests
24.4. Market Value Forecast, by Sample Type, 2020-2035
24.4.1. Whole Blood
24.4.2. Serum / Plasma
24.4.3. Saliva
24.4.4. Cerebrospinal Fluid
24.4.5. Others
24.5. Market Value Forecast, by End-user, 2020-2035
24.5.1. Hospitals and Clinics
24.5.2. Diagnostic Laboratories
24.5.3. Home Care Settings
24.5.4. Others
24.6. Market Attractiveness Analysis
24.6.1. By Product & Service
24.6.2. By Technology
24.6.3. By Sample Type
24.6.4. By End-user
25. Japan Dengue Testing Market Analysis and Forecast
25.1. Introduction
25.1.1. Key Findings
25.2. Market Value Forecast, by Product & Service, 2020-2035
25.2.1. Diagnostic Kits
25.2.1.1. Rapid Diagnostic Tests (RDTs)
25.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
25.2.1.3. Polymerase Chain Reaction (PCR) Tests
25.2.1.4. Dengue IgG/IgM Detection Kits
25.2.1.5. Lateral Flow Immunoassay
25.2.1.6. Others
25.2.2. Services
25.2.2.1. Laboratory Services
25.2.2.2. Point-of-Care Services
25.3. Market Value Forecast, by Technology, 2020-2035
25.3.1. Molecular Diagnostics
25.3.2. Serological Tests
25.3.3. Antigen Detection Tests
25.4. Market Value Forecast, by Sample Type, 2020-2035
25.4.1. Whole Blood
25.4.2. Serum / Plasma
25.4.3. Saliva
25.4.4. Cerebrospinal Fluid
25.4.5. Others
25.5. Market Value Forecast, by End-user, 2020-2035
25.5.1. Hospitals and Clinics
25.5.2. Diagnostic Laboratories
25.5.3. Home Care Settings
25.5.4. Others
25.6. Market Attractiveness Analysis
25.6.1. By Product & Service
25.6.2. By Technology
25.6.3. By Sample Type
25.6.4. By End-user
26. South Korea Dengue Testing Market Analysis and Forecast
26.1. Introduction
26.1.1. Key Findings
26.2. Market Value Forecast, by Product & Service, 2020-2035
26.2.1. Diagnostic Kits
26.2.1.1. Rapid Diagnostic Tests (RDTs)
26.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
26.2.1.3. Polymerase Chain Reaction (PCR) Tests
26.2.1.4. Dengue IgG/IgM Detection Kits
26.2.1.5. Lateral Flow Immunoassay
26.2.1.6. Others
26.2.2. Services
26.2.2.1. Laboratory Services
26.2.2.2. Point-of-Care Services
26.3. Market Value Forecast, by Technology, 2020-2035
26.3.1. Molecular Diagnostics
26.3.2. Serological Tests
26.3.3. Antigen Detection Tests
26.4. Market Value Forecast, by Sample Type, 2020-2035
26.4.1. Whole Blood
26.4.2. Serum / Plasma
26.4.3. Saliva
26.4.4. Cerebrospinal Fluid
26.4.5. Others
26.5. Market Value Forecast, by End-user, 2020-2035
26.5.1. Hospitals and Clinics
26.5.2. Diagnostic Laboratories
26.5.3. Home Care Settings
26.5.4. Others
26.6. Market Attractiveness Analysis
26.6.1. By Product & Service
26.6.2. By Technology
26.6.3. By Sample Type
26.6.4. By End-user
27. Australia & New Zealand Dengue Testing Market Analysis and Forecast
27.1. Introduction
27.1.1. Key Findings
27.2. Market Value Forecast, by Product & Service, 2020-2035
27.2.1. Diagnostic Kits
27.2.1.1. Rapid Diagnostic Tests (RDTs)
27.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
27.2.1.3. Polymerase Chain Reaction (PCR) Tests
27.2.1.4. Dengue IgG/IgM Detection Kits
27.2.1.5. Lateral Flow Immunoassay
27.2.1.6. Others
27.2.2. Services
27.2.2.1. Laboratory Services
27.2.2.2. Point-of-Care Services
27.3. Market Value Forecast, by Technology, 2020-2035
27.3.1. Molecular Diagnostics
27.3.2. Serological Tests
27.3.3. Antigen Detection Tests
27.4. Market Value Forecast, by Sample Type, 2020-2035
27.4.1. Whole Blood
27.4.2. Serum / Plasma
27.4.3. Saliva
27.4.4. Cerebrospinal Fluid
27.4.5. Others
27.5. Market Value Forecast, by End-user, 2020-2035
27.5.1. Hospitals and Clinics
27.5.2. Diagnostic Laboratories
27.5.3. Home Care Settings
27.5.4. Others
27.6. Market Attractiveness Analysis
27.6.1. By Product & Service
27.6.2. By Technology
27.6.3. By Sample Type
27.6.4. By End-user
28. ASEAN Dengue Testing Market Analysis and Forecast
28.1. Introduction
28.1.1. Key Findings
28.2. Market Value Forecast, by Product & Service, 2020-2035
28.2.1. Diagnostic Kits
28.2.1.1. Rapid Diagnostic Tests (RDTs)
28.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
28.2.1.3. Polymerase Chain Reaction (PCR) Tests
28.2.1.4. Dengue IgG/IgM Detection Kits
28.2.1.5. Lateral Flow Immunoassay
28.2.1.6. Others
28.2.2. Services
28.2.2.1. Laboratory Services
28.2.2.2. Point-of-Care Services
28.3. Market Value Forecast, by Technology, 2020-2035
28.3.1. Molecular Diagnostics
28.3.2. Serological Tests
28.3.3. Antigen Detection Tests
28.4. Market Value Forecast, by Sample Type, 2020-2035
28.4.1. Whole Blood
28.4.2. Serum / Plasma
28.4.3. Saliva
28.4.4. Cerebrospinal Fluid
28.4.5. Others
28.5. Market Value Forecast, by End-user, 2020-2035
28.5.1. Hospitals and Clinics
28.5.2. Diagnostic Laboratories
28.5.3. Home Care Settings
28.5.4. Others
28.6. Market Attractiveness Analysis
28.6.1. By Product & Service
28.6.2. By Technology
28.6.3. By Sample Type
28.6.4. By End-user
29. Rest of Asia Pacific Dengue Testing Market Analysis and Forecast
29.1. Introduction
29.1.1. Key Findings
29.2. Market Value Forecast, by Product & Service, 2020-2035
29.2.1. Diagnostic Kits
29.2.1.1. Rapid Diagnostic Tests (RDTs)
29.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
29.2.1.3. Polymerase Chain Reaction (PCR) Tests
29.2.1.4. Dengue IgG/IgM Detection Kits
29.2.1.5. Lateral Flow Immunoassay
29.2.1.6. Others
29.2.2. Services
29.2.2.1. Laboratory Services
29.2.2.2. Point-of-Care Services
29.3. Market Value Forecast, by Technology, 2020-2035
29.3.1. Molecular Diagnostics
29.3.2. Serological Tests
29.3.3. Antigen Detection Tests
29.4. Market Value Forecast, by Sample Type, 2020-2035
29.4.1. Whole Blood
29.4.2. Serum / Plasma
29.4.3. Saliva
29.4.4. Cerebrospinal Fluid
29.4.5. Others
29.5. Market Value Forecast, by End-user, 2020-2035
29.5.1. Hospitals and Clinics
29.5.2. Diagnostic Laboratories
29.5.3. Home Care Settings
29.5.4. Others
29.6. Market Attractiveness Analysis
29.6.1. By Product & Service
29.6.2. By Technology
29.6.3. By Sample Type
29.6.4. By End-user
30. Latin America Dengue Testing Market Analysis and Forecast
30.1. Introduction
30.1.1. Key Findings
30.2. Market Value Forecast, by Product & Service, 2020-2035
30.2.1. Diagnostic Kits
30.2.1.1. Rapid Diagnostic Tests (RDTs)
30.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
30.2.1.3. Polymerase Chain Reaction (PCR) Tests
30.2.1.4. Dengue IgG/IgM Detection Kits
30.2.1.5. Lateral Flow Immunoassay
30.2.1.6. Others
30.2.2. Services
30.2.2.1. Laboratory Services
30.2.2.2. Point-of-Care Services
30.3. Market Value Forecast, by Technology, 2020-2035
30.3.1. Molecular Diagnostics
30.3.2. Serological Tests
30.3.3. Antigen Detection Tests
30.4. Market Value Forecast, by Sample Type, 2020-2035
30.4.1. Whole Blood
30.4.2. Serum / Plasma
30.4.3. Saliva
30.4.4. Cerebrospinal Fluid
30.4.5. Others
30.5. Market Value Forecast, by End-user, 2020-2035
30.5.1. Hospitals and Clinics
30.5.2. Diagnostic Laboratories
30.5.3. Home Care Settings
30.5.4. Others
30.6. Market Value Forecast, by Country/Sub-region, 2020-2035
30.6.1. Brazil
30.6.2. Argentina
30.6.3. Mexico
30.6.4. Rest of Latin America
30.7. Market Attractiveness Analysis
30.7.1. By Product & Service
30.7.2. By Technology
30.7.3. By Sample Type
30.7.4. By End-user
30.7.5. By Country/Sub-region
31. Brazil Dengue Testing Market Analysis and Forecast
31.1. Introduction
31.1.1. Key Findings
31.2. Market Value Forecast, by Product & Service, 2020-2035
31.2.1. Diagnostic Kits
31.2.1.1. Rapid Diagnostic Tests (RDTs)
31.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
31.2.1.3. Polymerase Chain Reaction (PCR) Tests
31.2.1.4. Dengue IgG/IgM Detection Kits
31.2.1.5. Lateral Flow Immunoassay
31.2.1.6. Others
31.2.2. Services
31.2.2.1. Laboratory Services
31.2.2.2. Point-of-Care Services
31.3. Market Value Forecast, by Technology, 2020-2035
31.3.1. Molecular Diagnostics
31.3.2. Serological Tests
31.3.3. Antigen Detection Tests
31.4. Market Value Forecast, by Sample Type, 2020-2035
31.4.1. Whole Blood
31.4.2. Serum / Plasma
31.4.3. Saliva
31.4.4. Cerebrospinal Fluid
31.4.5. Others
31.5. Market Value Forecast, by End-user, 2020-2035
31.5.1. Hospitals and Clinics
31.5.2. Diagnostic Laboratories
31.5.3. Home Care Settings
31.5.4. Others
31.6. Market Attractiveness Analysis
31.6.1. By Product & Service
31.6.2. By Technology
31.6.3. By Sample Type
31.6.4. By End-user
32. Argentina Dengue Testing Market Analysis and Forecast
32.1. Introduction
32.1.1. Key Findings
32.2. Market Value Forecast, by Product & Service, 2020-2035
32.2.1. Diagnostic Kits
32.2.1.1. Rapid Diagnostic Tests (RDTs)
32.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
32.2.1.3. Polymerase Chain Reaction (PCR) Tests
32.2.1.4. Dengue IgG/IgM Detection Kits
32.2.1.5. Lateral Flow Immunoassay
32.2.1.6. Others
32.2.2. Services
32.2.2.1. Laboratory Services
32.2.2.2. Point-of-Care Services
32.3. Market Value Forecast, by Technology, 2020-2035
32.3.1. Molecular Diagnostics
32.3.2. Serological Tests
32.3.3. Antigen Detection Tests
32.4. Market Value Forecast, by Sample Type, 2020-2035
32.4.1. Whole Blood
32.4.2. Serum / Plasma
32.4.3. Saliva
32.4.4. Cerebrospinal Fluid
32.4.5. Others
32.5. Market Value Forecast, by End-user, 2020-2035
32.5.1. Hospitals and Clinics
32.5.2. Diagnostic Laboratories
32.5.3. Home Care Settings
32.5.4. Others
32.6. Market Attractiveness Analysis
32.6.1. By Product & Service
32.6.2. By Technology
32.6.3. By Sample Type
32.6.4. By End-user
33. Mexico Dengue Testing Market Analysis and Forecast
33.1. Introduction
33.1.1. Key Findings
33.2. Market Value Forecast, by Product & Service, 2020-2035
33.2.1. Diagnostic Kits
33.2.1.1. Rapid Diagnostic Tests (RDTs)
33.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
33.2.1.3. Polymerase Chain Reaction (PCR) Tests
33.2.1.4. Dengue IgG/IgM Detection Kits
33.2.1.5. Lateral Flow Immunoassay
33.2.1.6. Others
33.2.2. Services
33.2.2.1. Laboratory Services
33.2.2.2. Point-of-Care Services
33.3. Market Value Forecast, by Technology, 2020-2035
33.3.1. Molecular Diagnostics
33.3.2. Serological Tests
33.3.3. Antigen Detection Tests
33.4. Market Value Forecast, by Sample Type, 2020-2035
33.4.1. Whole Blood
33.4.2. Serum / Plasma
33.4.3. Saliva
33.4.4. Cerebrospinal Fluid
33.4.5. Others
33.5. Market Value Forecast, by End-user, 2020-2035
33.5.1. Hospitals and Clinics
33.5.2. Diagnostic Laboratories
33.5.3. Home Care Settings
33.5.4. Others
33.6. Market Attractiveness Analysis
33.6.1. By Product & Service
33.6.2. By Technology
33.6.3. By Sample Type
33.6.4. By End-user
34. Rest of Latin America Dengue Testing Market Analysis and Forecast
34.1. Introduction
34.1.1. Key Findings
34.2. Market Value Forecast, by Product & Service, 2020-2035
34.2.1. Diagnostic Kits
34.2.1.1. Rapid Diagnostic Tests (RDTs)
34.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
34.2.1.3. Polymerase Chain Reaction (PCR) Tests
34.2.1.4. Dengue IgG/IgM Detection Kits
34.2.1.5. Lateral Flow Immunoassay
34.2.1.6. Others
34.2.2. Services
34.2.2.1. Laboratory Services
34.2.2.2. Point-of-Care Services
34.3. Market Value Forecast, by Technology, 2020-2035
34.3.1. Molecular Diagnostics
34.3.2. Serological Tests
34.3.3. Antigen Detection Tests
34.4. Market Value Forecast, by Sample Type, 2020-2035
34.4.1. Whole Blood
34.4.2. Serum / Plasma
34.4.3. Saliva
34.4.4. Cerebrospinal Fluid
34.4.5. Others
34.5. Market Value Forecast, by End-user, 2020-2035
34.5.1. Hospitals and Clinics
34.5.2. Diagnostic Laboratories
34.5.3. Home Care Settings
34.5.4. Others
34.6. Market Attractiveness Analysis
34.6.1. By Product & Service
34.6.2. By Technology
34.6.3. By Sample Type
34.6.4. By End-user
35. Middle East & Africa Dengue Testing Market Analysis and Forecast
35.1. Introduction
35.1.1. Key Findings
35.2. Market Value Forecast, by Product & Service, 2020-2035
35.2.1. Diagnostic Kits
35.2.1.1. Rapid Diagnostic Tests (RDTs)
35.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
35.2.1.3. Polymerase Chain Reaction (PCR) Tests
35.2.1.4. Dengue IgG/IgM Detection Kits
35.2.1.5. Lateral Flow Immunoassay
35.2.1.6. Others
35.2.2. Services
35.2.2.1. Laboratory Services
35.2.2.2. Point-of-Care Services
35.3. Market Value Forecast, by Technology, 2020-2035
35.3.1. Molecular Diagnostics
35.3.2. Serological Tests
35.3.3. Antigen Detection Tests
35.4. Market Value Forecast, by Sample Type, 2020-2035
35.4.1. Whole Blood
35.4.2. Serum / Plasma
35.4.3. Saliva
35.4.4. Cerebrospinal Fluid
35.4.5. Others
35.5. Market Value Forecast, by End-user, 2020-2035
35.5.1. Hospitals and Clinics
35.5.2. Diagnostic Laboratories
35.5.3. Home Care Settings
35.5.4. Others
35.6. Market Value Forecast, by Country/Sub-region, 2020-2035
35.6.1. GCC Countries
35.6.2. South Africa
35.6.3. Rest of Middle East & Africa
35.7. Market Attractiveness Analysis
35.7.1. By Product & Service
35.7.2. By Technology
35.7.3. By Sample Type
35.7.4. By End-user
35.7.5. By Country/Sub-region
36. GCC Countries Dengue Testing Market Analysis and Forecast
36.1. Introduction
36.1.1. Key Findings
36.2. Market Value Forecast, by Product & Service, 2020-2035
36.2.1. Diagnostic Kits
36.2.1.1. Rapid Diagnostic Tests (RDTs)
36.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
36.2.1.3. Polymerase Chain Reaction (PCR) Tests
36.2.1.4. Dengue IgG/IgM Detection Kits
36.2.1.5. Lateral Flow Immunoassay
36.2.1.6. Others
36.2.2. Services
36.2.2.1. Laboratory Services
36.2.2.2. Point-of-Care Services
36.3. Market Value Forecast, by Technology, 2020-2035
36.3.1. Molecular Diagnostics
36.3.2. Serological Tests
36.3.3. Antigen Detection Tests
36.4. Market Value Forecast, by Sample Type, 2020-2035
36.4.1. Whole Blood
36.4.2. Serum / Plasma
36.4.3. Saliva
36.4.4. Cerebrospinal Fluid
36.4.5. Others
36.5. Market Value Forecast, by End-user, 2020-2035
36.5.1. Hospitals and Clinics
36.5.2. Diagnostic Laboratories
36.5.3. Home Care Settings
36.5.4. Others
36.6. Market Attractiveness Analysis
36.6.1. By Product & Service
36.6.2. By Technology
36.6.3. By Sample Type
36.6.4. By End-user
37. South Africa Dengue Testing Market Analysis and Forecast
37.1. Introduction
37.1.1. Key Findings
37.2. Market Value Forecast, by Product & Service, 2020-2035
37.2.1. Diagnostic Kits
37.2.1.1. Rapid Diagnostic Tests (RDTs)
37.2.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
37.2.1.3. Polymerase Chain Reaction (PCR) Tests
37.2.1.4. Dengue IgG/IgM Detection Kits
37.2.1.5. Lateral Flow Immunoassay
37.2.1.6. Others
37.2.2. Services
37.2.2.1. Laboratory Services
37.2.2.2. Point-of-Care Services
37.3. Market Value Forecast, by Technology, 2020-2035
37.3.1. Molecular Diagnostics
37.3.2. Serological Tests
37.3.3. Antigen Detection Tests
37.4. Market Value Forecast, by Sample Type, 2020-2035
37.4.1. Whole Blood
37.4.2. Serum / Plasma
37.4.3. Saliva
37.4.4. Cerebrospinal Fluid
37.4.5. Others
37.5. Market Value Forecast, by End-user, 2020-2035
37.5.

ページTOPに戻る

List of Tables/Graphs

List of Figures
Figure 01: Global Dengue Testing Market Value Share Analysis, By Product & Service, 2024 and 2035
Figure 02: Global Dengue Testing Market Attractiveness Analysis, By Product & Service, 2025 to 2035
Figure 03: Global Dengue Testing Market Revenue (US$ Mn), by Diagnostic Kits, 2020 to 2035
Figure 04: Global Dengue Testing Market Revenue (US$ Mn), by Services, 2020 to 2035
Figure 05: Global Dengue Testing Market Value Share Analysis, By Technology, 2024 and 2035
Figure 06: Global Dengue Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
Figure 07: Global Dengue Testing Market Revenue (US$ Mn), by Molecular Diagnostics, 2020 to 2035
Figure 08: Global Dengue Testing Market Revenue (US$ Mn), by Serological Tests, 2020 to 2035
Figure 09: Global Dengue Testing Market Revenue (US$ Mn), by Antigen Detection Tests, 2020 to 2035
Figure 10: Global Dengue Testing Market Value Share Analysis, By Sample Type, 2024 and 2035
Figure 11: Global Dengue Testing Market Attractiveness Analysis, By Sample Type, 2025 to 2035
Figure 12: Global Dengue Testing Market Revenue (US$ Mn), by Whole Blood, 2020 to 2035
Figure 13: Global Dengue Testing Market Revenue (US$ Mn), by Serum / Plasma, 2020 to 2035
Figure 14: Global Dengue Testing Market Revenue (US$ Mn), by Saliva, 2020 to 2035
Figure 15: Global Dengue Testing Market Revenue (US$ Mn), by Cerebrospinal Fluid, 2020 to 2035
Figure 16: Global Dengue Testing Market Revenue (US$ Mn), by Others, 2020 to 2035
Figure 17: Global Dengue Testing Market Value Share Analysis, By End-user, 2024 and 2035
Figure 18: Global Dengue Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 19: Global Dengue Testing Market Revenue (US$ Mn), by Hospitals and Clinics, 2020 to 2035
Figure 20: Global Dengue Testing Market Revenue (US$ Mn), by Diagnostic Laboratories, 2020 to 2035
Figure 21: Global Dengue Testing Market Revenue (US$ Mn), by Home Care Settings, 2020 to 2035
Figure 22: Global Dengue Testing Market Revenue (US$ Mn), by Others, 2020 to 2035
Figure 23: Global Dengue Testing Market Value Share Analysis, By Region, 2024 and 2035
Figure 24: Global Dengue Testing Market Attractiveness Analysis, By Region, 2025 to 2035
Figure 25: North America Dengue Testing Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 26: North America Dengue Testing Market Value Share Analysis, by Country, 2024 and 2035
Figure 27: North America Dengue Testing Market Attractiveness Analysis, by Country, 2025 to 2035
Figure 28: North America Dengue Testing Market Value Share Analysis, By Product & Service, 2024 and 2035
Figure 29: North America Dengue Testing Market Attractiveness Analysis, By Product & Service, 2025 to 2035
Figure 30: North America Dengue Testing Market Value Share Analysis, By Technology, 2024 and 2035
Figure 31: North America Dengue Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
Figure 32: North America Dengue Testing Market Value Share Analysis, By Sample Type, 2024 and 2035
Figure 33: North America Dengue Testing Market Attractiveness Analysis, By Sample Type, 2025 to 2035
Figure 34: North America Dengue Testing Market Value Share Analysis, By End-user, 2024 and 2035
Figure 35: North America Dengue Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 36: Europe Dengue Testing Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 37: Europe Dengue Testing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 38: Europe Dengue Testing Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 39: Europe Dengue Testing Market Value Share Analysis, By Product & Service, 2024 and 2035
Figure 40: Europe Dengue Testing Market Attractiveness Analysis, By Product & Service, 2025 to 2035
Figure 41: Europe Dengue Testing Market Value Share Analysis, By Technology, 2024 and 2035
Figure 42: Europe Dengue Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
Figure 43: Europe Dengue Testing Market Value Share Analysis, By Sample Type, 2024 and 2035
Figure 44: Europe Dengue Testing Market Attractiveness Analysis, By Sample Type, 2025 to 2035
Figure 45: Europe Dengue Testing Market Value Share Analysis, By End-user, 2024 and 2035
Figure 46: Europe Dengue Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 47: Asia Pacific Dengue Testing Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 48: Asia Pacific Dengue Testing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 49: Asia Pacific Dengue Testing Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 50: Asia Pacific Dengue Testing Market Value Share Analysis, By Product & Service, 2024 and 2035
Figure 51: Asia Pacific Dengue Testing Market Attractiveness Analysis, By Product & Service, 2025 to 2035
Figure 52: Asia Pacific Dengue Testing Market Value Share Analysis, By Technology, 2024 and 2035
Figure 53: Asia Pacific Dengue Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
Figure 54: Asia Pacific Dengue Testing Market Value Share Analysis, By Sample Type, 2024 and 2035
Figure 55: Asia Pacific Dengue Testing Market Attractiveness Analysis, By Sample Type, 2025 to 2035
Figure 56: Asia Pacific Dengue Testing Market Value Share Analysis, By End-user, 2024 and 2035
Figure 57: Asia Pacific Dengue Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 58: Latin America Dengue Testing Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 59: Latin America Dengue Testing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 60: Latin America Dengue Testing Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 61: Latin America Dengue Testing Market Value Share Analysis, By Product & Service, 2024 and 2035
Figure 62: Latin America Dengue Testing Market Attractiveness Analysis, By Product & Service, 2025 to 2035
Figure 63: Latin America Dengue Testing Market Value Share Analysis, By Technology, 2024 and 2035
Figure 64: Latin America Dengue Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
Figure 65: Latin America Dengue Testing Market Value Share Analysis, By Sample Type, 2024 and 2035
Figure 66: Latin America Dengue Testing Market Attractiveness Analysis, By Sample Type, 2025 to 2035
Figure 67: Latin America Dengue Testing Market Value Share Analysis, By End-user, 2024 and 2035
Figure 68: Latin America Dengue Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 69: Middle East & Africa Dengue Testing Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 70: Middle East & Africa Dengue Testing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 71: Middle East & Africa Dengue Testing Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 72: Middle East & Africa Dengue Testing Market Value Share Analysis, By Product & Service, 2024 and 2035
Figure 73: Middle East & Africa Dengue Testing Market Attractiveness Analysis, By Product & Service, 2025 to 2035
Figure 74: Middle East & Africa Dengue Testing Market Value Share Analysis, By Technology, 2024 and 2035
Figure 75: Middle East & Africa Dengue Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
Figure 76: Middle East & Africa Dengue Testing Market Value Share Analysis, By Sample Type, 2024 and 2035
Figure 77: Middle East & Africa Dengue Testing Market Attractiveness Analysis, By Sample Type, 2025 to 2035
Figure 78: Middle East & Africa Dengue Testing Market Value Share Analysis, By End-user, 2024 and 2035
Figure 79: Middle East & Africa Dengue Testing Market Attractiveness Analysis, By End-user, 2025 to 2035